Cardiogenomics Testing Panels Global Market Report 2025
상품코드:1855814
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
Cardiogenomics 검사 패널 시장 규모는 최근 급속히 확대하고 있습니다. 2024년 13억 8,000만 달러에서 2025년에는 15억 5,000만 달러로, CAGR 12.7%로 확대합니다. 실적 기간의 성장은 유전학 검사에 대한 상환 정책 확대, 유전 상담 서비스 증가, 조기 진단 및 예방에 대한 강조, 일반 대중의 인식 개선 노력, 원격의료 및 원격 진단의 광범위한 채택에 기인합니다.
카디오게놈 검사 패널 시장 규모는 향후 수년간 급성장할 것으로 예측됩니다. 2029년에는 CAGR 12.4%로 24억 8,000만 달러로 성장할 것입니다. 예측 기간 중의 성장은 심혈관 질환의 유병률 증가, 유전적 소인에 대한 인식 증가, 맞춤형 의료에 대한 수요 증가, 차세대 시퀀싱 장비의 가용성 확대, 유전체학에 대한 헬스케어 투자 증가에 기인합니다. 예측 기간의 주요 동향으로는 차세대 시퀀서의 발전, 데이터 분석을 위한 인공지능의 통합, 멀티진 패널의 개발, 마이크로어레이 기술의 발전, 전자의무기록에 유전체 데이터 통합 등을 꼽을 수 있습니다.
카디오게놈 검사 패널은 심근증, 부정맥, 가족성 고콜레스테롤혈증 등 심혈관 질환의 유전적 위험을 판단하기 위해 여러 유전자를 검사하는 유전자 검사입니다. 조기 진단, 개인별 맞춤 치료, 가족 위험도 평가를 지원합니다.
카디오게놈 검사 패널의 주요 제품 유형은 단일 유전자 패널, 다중 유전자 패널, 전체 엑솜 시퀀싱 패널입니다. 단일 유전자 패널은 특정 유전자를 검사하여 특정 유전성 질환 및 질병과 관련된 돌연변이 및 변이를 검출합니다. 차세대 시퀀싱, PCR 기반 검사, 마이크로어레이 등 다양한 기술이 적용되고 있습니다. 이 패널은 유전성 심혈관계 질환, 부정맥, 심근증, 선천성 심장병 등의 분야에 적용되어 병원, 클리닉, 진단 실험실, 학술 및 연구기관, 기타 최종사용자들이 사용하고 있습니다.
미국의 급속한 관세 인상과 2025년 봄까지 이어지는 무역 마찰은 의료기기 분야, 특히 수입 영상 진단기기 부품, 수술용 스테인리스강, 플라스틱 소모품에 큰 영향을 미치고 있습니다. 병원 및 진료소는 가격 인상에 저항하며 제조업체의 이윤을 압박하고 있습니다. 관세와 관련된 공급업체 변경은 종종 장비의 재인증을 필요로 하고, 시장 출시 시간을 지연시키는 등 규제상의 장애물이 문제를 복잡하게 만듭니다. 기업은 핵심 부품의 이중 조달, 상품화된 품목의 국내 생산 확대, 비용 효율적인 소재의 연구개발 가속화 등을 통해 리스크를 줄이고 있습니다.
이 조사 보고서는 카디오유전체학 검사 패널 산업 세계 시장 규모, 지역 점유율, 카디오유전체학 검사 패널 시장 점유율을 가진 경쟁업체, 상세한 카디오유전체학 검사 패널 시장 부문, 시장 동향 및 비즈니스 기회, 카디오유전체학 검사 패널 산업에서 성공하기 위해 필요한 데이터 성공하기 위해 필요한 데이터 등을 제공하는 The Business Research Company의 새로운 보고서 시리즈 중 하나인 카디오유전체학 검사 패널 시장 통계를 제공합니다. 이 심장 유전체학 검사 패널 시장 조사 보고서는 업계의 현재와 미래 시나리오를 자세히 분석하여 필요한 모든 것을 완벽한 관점으로 제공합니다.
유전성 심혈관계 질환의 유병률 증가는 심장 유전체학 검사 패널 시장의 성장을 가속할 것으로 예측됩니다. 유전성 심혈관계 질환(ICD)은 부모로부터 자식에게 유전적으로 물려받는 심장 및 혈관 질환을 말합니다. 유전자 검사와 진단의 발전으로 인해 지금까지 밝혀지지 않았던 질병을 보다 정확하게 발견할 수 있게 되어 진단 사례 증가에 기여하고 있습니다. 카디오게놈 검사 패널은 유전성 심장질환을 유발하는 유전자 변이를 분석하여 유전성 심혈관계 질환의 조기 진단, 위험도 평가, 개인별 맞춤 치료 계획을 용이하게 해줍니다. 예를 들어 2025년 2월 영국의 지역 보건 센터인 Joint Strategic Needs Assessment는 블랙풀이 2022년 178명 대비 2023년 185명의 심혈관 질환으로 인한 사망자를 기록했다고 보고했습니다. 이러한 유병률 증가는 심장유전체학 검사 패널 시장 확대에 박차를 가하고 있습니다.
헬스케어 지출 증가는 심장 유전체학 검사 패널 시장을 촉진할 것으로 예측됩니다. 보건의료 지출에는 정부, 민간단체, 개인이 보건의료 서비스 및 의료를 제공, 유지, 개선하기 위해 지출하는 총 자원이 포함됩니다. 지출 증가는 장기적인 관리, 지속적인 모니터링, 전문적인 개입이 필요한 만성질환의 부담이 증가했기 때문입니다. 이러한 지출은 유전성 심혈관 질환의 조기 발견 및 예방, 환자 예후 개선, 장기적인 비용 절감을 위한 고급 유전자 분석에 자금을 지원함으로써 심장유전체학 검사 패널을 지원하고 있습니다. 예를 들어 2023년 12월 미국 연방정부 기관인 메디케어 및 메디케이드 서비스 센터는 미국의 의료비 지출이 2022년 4.1% 증가하여 2021년 3.2% 증가한 4조 5,000억 달러에 달할 것이라고 보고했습니다. 이 같은 추세는 심장 유전체학 검사 패널 시장 성장에 기여하고 있습니다.
2022년 3월, 미국 헬스케어 솔루션 프로바이더인 렛츠겟체크드(LetsGetChecked)는 베리타스 제네틱스(Veritas Genetics Inc.)와 베리타스 인터컨티넨탈(Veritas Intercontinental S.L.)을 미공개 금액으로 인수했습니다. 이번 인수는 전장유전체 시퀀싱을 활용하여 상세한 유전자 데이터를 확장 가능한 진단 및 가상 치료 플랫폼에 통합함으로써 종합적인 개인 맞춤형 헬스케어 수명주기를 제공하고, 임상 전문가가 실행 가능한 권장 사항과 생활습관 지도를 제공하는 것을 목표로 하고 있습니다. Veritas Genetics Inc.와 Intercontinental S.L.은 심장 유전체학 검사 패널을 제공하는 미국 생명공학 기업입니다.
카디오게놈 검사 패널 시장은 유전자 위험도 평가, 조기 진단, 개인별 맞춤 치료 계획 등의 서비스를 제공하는 사업체의 매출으로 구성됩니다. 시장 가치에는 서비스 프로바이더가 판매하거나 서비스 제공에 포함된 관련 상품의 가치도 포함됩니다. 심장 유전체학 검사 패널 시장에는 종합적인 심근병증 패널, 심장 부정맥 패널, 소비자 직접 판매 유전체 프로파일 판매도 포함됩니다. 이 시장의 가치는 '팩토리 게이트(공장 출고 시)' 가치, 즉 상품의 생산자 또는 제조업체가 다른 사업체(다운스트림 생산자, 도매업체, 유통업체, 소매업체 등) 또는 최종 고객에게 직접 판매한 상품의 가치입니다. 이 시장에서 상품의 가치에는 상품을 만든 사람이 판매하는 관련 서비스도 포함됩니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 Cardiogenomics 검사 패널 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 Cardiogenomics 검사 패널 시장 : 성장률 분석
세계의 Cardiogenomics 검사 패널 시장 실적 : 규모와 성장, 2019-2024
세계의 Cardiogenomics 검사 패널 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 Cardiogenomics 검사 패널 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 Cardiogenomics 검사 패널 시장 : 제품 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
단일 유전자 패널
멀티 유전자 패널
전엑솜 시퀀스 패널
세계의 Cardiogenomics 검사 패널 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
차세대 시퀸서
PCR 기반 검사
마이크로어레이
기타 테크놀러지
세계의 Cardiogenomics 검사 패널 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
유전성 심혈관계 질환
부정맥
심근증
선천성 심질환
기타 애플리케이션
세계의 Cardiogenomics 검사 패널 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원과 클리닉
진단 연구소
학술연구기관
기타 최종사용자
세계의 Cardiogenomics 검사 패널 시장 : 서브 세분화 단일 유전자 패널, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
이온채널 유전자 패널
심장 구조 질환 유전자 패널
부정맥 유전자 패널
세계의 Cardiogenomics 검사 패널 시장 : 서브 세분화 멀티 유전자 패널, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
심근증 패널
부정맥 패널
선천성 심질환 패널
세계의 Cardiogenomics 검사 패널 시장 : 서브 세분화 전엑솜 시퀀스 패널, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
타겟 심혈관 엑솜 패널
종합적 엑솜 패널
조사용 엑솜 패널
제7장 지역별·국가별 분석
세계의 Cardiogenomics 검사 패널 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 Cardiogenomics 검사 패널 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
Cardiogenomics 검사 패널 시장 : 경쟁 구도
Cardiogenomics 검사 패널 시장 : 기업 개요
F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific, Inc. Overview, Products and Services, Strategy and Financial Analysis
Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Illumina Inc.
Actia Group
Invitae Corporation
Fulgent Genetics Inc.
GeneDx Inc.
Ambry Genetics Corporation
Helix OpCo Inc.
Centogene Gmbh
Blueprint Genetics Inc.
Strand Life Sciences Pvt. Ltd.
Genes2Me Pvt. Ltd.
BioAro Inc.
GENinCode Plc
Igenomix S.L.
Asper Biotech Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
Cardiogenomics 검사 패널 시장 2029 : 새로운 기회를 제공하는 국가
Cardiogenomics 검사 패널 시장 2029 : 새로운 기회를 제공하는 부문
Cardiogenomics 검사 패널 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Cardiogenomics testing panels are genetic tests that examine multiple genes to determine inherited risks for cardiovascular diseases, including cardiomyopathies, arrhythmias, and familial hypercholesterolemia. They support early diagnosis, personalized treatment, and assessment of family risk.
The primary product types of cardiogenomics testing panels are single-gene panels, multi-gene panels, and whole exome sequencing panels. Single-gene panels test a specific gene to detect mutations or variants linked to a particular inherited condition or disease. The technologies employed include next-generation sequencing, PCR-based testing, microarrays, and others. These panels are applied in areas such as inherited cardiovascular diseases, arrhythmias, cardiomyopathies, congenital heart diseases, and others, and are used by hospitals and clinics, diagnostic laboratories, academic and research institutions, and other end users.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The cardiogenomics testing panels market research report is one of a series of new reports from The Business Research Company that provides cardiogenomics testing panels market statistics, including cardiogenomics testing panels industry global market size, regional shares, competitors with a cardiogenomics testing panels market share, detailed cardiogenomics testing panels market segments, market trends and opportunities, and any further data you may need to thrive in the cardiogenomics testing panels industry. This cardiogenomics testing panels market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cardiogenomics testing panels market size has grown rapidly in recent years. It will grow from $1.38 billion in 2024 to $1.55 billion in 2025 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to expanding reimbursement policies for genetic tests, an increasing number of genetic counseling services, greater focus on early diagnosis and prevention, rising public awareness initiatives, and wider adoption of telemedicine and remote diagnostics.
The cardiogenomics testing panels market size is expected to see rapid growth in the next few years. It will grow to $2.48 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to the increasing prevalence of cardiovascular diseases, growing awareness of genetic predispositions, higher demand for personalized medicine, greater availability of next-generation sequencing, and rising healthcare investments in genomics. Key trends in the forecast period include advancements in next-generation sequencing, integration of artificial intelligence for data analysis, development of multi-gene panels, progress in microarray technology, and incorporation of genomic data with electronic health records.
The rising prevalence of inherited cardiovascular diseases is expected to drive growth in the cardiogenomics testing panels market. Inherited cardiovascular diseases (ICDs) include heart and blood vessel disorders passed down genetically from parents to offspring. Advances in genetic testing and diagnostics have contributed to an increase in diagnosed cases by enabling more precise detection of previously unidentified conditions. Cardiogenomics testing panels assist in inherited cardiovascular diseases by analyzing genetic mutations responsible for hereditary heart disorders, facilitating early diagnosis, risk evaluation, and personalized treatment plans. For example, in February 2025, the Joint Strategic Needs Assessment, a UK community health center, reported that Blackpool recorded 185 cardiovascular disease deaths in 2023 compared to 178 in 2022. This growing prevalence is fueling expansion in the cardiogenomics testing panels market.
Increasing healthcare expenditure is anticipated to boost the cardiogenomics testing panels market. Healthcare expenditure encompasses the total resources spent by governments, private entities, and individuals on delivering, maintaining, and improving health services and medical care. The rise in spending is driven by the growing burden of chronic diseases that require long-term management, ongoing monitoring, and specialized interventions. These expenditures support cardiogenomics testing panels by funding advanced genetic analyses that enable early detection and prevention of inherited cardiovascular conditions, improving patient outcomes and lowering long-term costs. For instance, in December 2023, the Centers for Medicare & Medicaid Services, a US federal agency, reported that healthcare spending in the US increased by 4.1% in 2022, reaching $4.5 trillion, up from 3.2% growth in 2021. This trend contributes to market growth in cardiogenomics testing panels.
In March 2022, LetsGetChecked, a US healthcare solutions provider, acquired Veritas Genetics Inc. and Veritas Intercontinental S.L. for an undisclosed amount. This acquisition aims to utilize whole genome sequencing to offer a comprehensive personalized healthcare lifecycle by integrating detailed genetic data into scalable diagnostic and virtual care platforms, delivering actionable recommendations and lifestyle guidance from clinical experts. Veritas Genetics Inc. and Intercontinental S.L. are US-based biotechnology firms providing cardiogenomics testing panels.
Major players in the cardiogenomics testing panels market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Illumina Inc., Actia Group, Invitae Corporation, Fulgent Genetics Inc., GeneDx Inc., Ambry Genetics Corporation, Helix OpCo Inc., Centogene Gmbh, Blueprint Genetics Inc., Strand Life Sciences Pvt. Ltd., Genes2Me Pvt. Ltd., BioAro Inc., GENinCode Plc, Igenomix S.L., Asper Biotech Ltd.
North America was the largest region in the cardiogenomics testing panels market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cardiogenomics testing panels report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the cardiogenomics testing panels market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cardiogenomics testing panels market consists of revenues earned by entities by providing services such as genetic risk assessment, early diagnosis, and personalized treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiogenomics testing panels market also includes sales of comprehensive cardiomyopathy panels, cardiac arrhythmia panels, and direct-to-consumer genomic profiles. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cardiogenomics Testing Panels Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cardiogenomics testing panels market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cardiogenomics testing panels ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiogenomics testing panels market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3. Cardiogenomics Testing Panels Market Trends And Strategies
4. Cardiogenomics Testing Panels Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Cardiogenomics Testing Panels Growth Analysis And Strategic Analysis Framework
5.1. Global Cardiogenomics Testing Panels PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cardiogenomics Testing Panels Market Growth Rate Analysis
5.4. Global Cardiogenomics Testing Panels Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cardiogenomics Testing Panels Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cardiogenomics Testing Panels Total Addressable Market (TAM)
6.1. Global Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single-Gene Panels
Multi-Gene Panels
Whole Exome Sequencing Panels
6.2. Global Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Next-Generation Sequencing
PCR-Based Testing
Microarray
Other Technologies
6.3. Global Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inherited Cardiovascular Diseases
Arrhythmias
Cardiomyopathies
Congenital Heart Diseases
Other Appications
6.4. Global Cardiogenomics Testing Panels Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Diagnostic Laboratories
Academic And Research Institutes
Other End Users
6.5. Global Cardiogenomics Testing Panels Market, Sub-Segmentation Of Single-Gene Panels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ion Channel Gene Panels
Structural Heart Disease Gene Panels
Arrhythmia Gene Panels
6.6. Global Cardiogenomics Testing Panels Market, Sub-Segmentation Of Multi-Gene Panels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiomyopathy Panels
Arrhythmia Panels
Congenital Heart Disease Panels
6.7. Global Cardiogenomics Testing Panels Market, Sub-Segmentation Of Whole Exome Sequencing Panels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Targeted Cardiovascular Exome Panels
Comprehensive Exome Panels
Research-Oriented Exome Panels
7. Cardiogenomics Testing Panels Market Regional And Country Analysis
7.1. Global Cardiogenomics Testing Panels Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cardiogenomics Testing Panels Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Cardiogenomics Testing Panels Market
9.1. China Cardiogenomics Testing Panels Market Overview
9.2. China Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Cardiogenomics Testing Panels Market
10.1. India Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Cardiogenomics Testing Panels Market
11.1. Japan Cardiogenomics Testing Panels Market Overview
11.2. Japan Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Cardiogenomics Testing Panels Market
12.1. Australia Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Cardiogenomics Testing Panels Market
13.1. Indonesia Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Cardiogenomics Testing Panels Market
14.1. South Korea Cardiogenomics Testing Panels Market Overview
14.2. South Korea Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Cardiogenomics Testing Panels Market
15.1. Western Europe Cardiogenomics Testing Panels Market Overview
15.2. Western Europe Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Cardiogenomics Testing Panels Market
16.1. UK Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Cardiogenomics Testing Panels Market
17.1. Germany Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Cardiogenomics Testing Panels Market
18.1. France Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Cardiogenomics Testing Panels Market
19.1. Italy Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Cardiogenomics Testing Panels Market
20.1. Spain Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Cardiogenomics Testing Panels Market
21.1. Eastern Europe Cardiogenomics Testing Panels Market Overview
21.2. Eastern Europe Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Cardiogenomics Testing Panels Market
22.1. Russia Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Cardiogenomics Testing Panels Market
23.1. North America Cardiogenomics Testing Panels Market Overview
23.2. North America Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Cardiogenomics Testing Panels Market
24.1. USA Cardiogenomics Testing Panels Market Overview
24.2. USA Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
